| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |